Cordelia Advisory is an independent strategic firm working where health systems, epidemiology, biotechnology, and artificial intelligence meet — helping governments, universities, and investors decide with rigor and act with confidence.
Muscat · GCC & International
Our only product is judgment. We sell no systems, license no platforms, and carry no conflicts into the room.
Epidemiology, medicine, data science, and institutional strategy — held together in one mind, rather than handed off between vendors.
Every recommendation is held to the standard of the academy, then made plain enough to act on by morning.
Cordelia Advisory exists for the moments when a decision is too consequential to be left to comfortable advice. We work with the institutions that carry the weight of a population's health — ministries, universities, hospitals, and the investors who fund what comes next — and we bring to them the rigor of the academy and the candour of an independent counsel.
We are deliberately an institution, not a personality. The firm is founded and led by a senior academic physician and epidemiologist, but it is built to outlast any single name: a standing capability, not a consultant's shingle.
We are not a clinic. We are not a vendor. We are the partner a serious institution turns to when it needs to see clearly and decide well.
To raise the quality of the most consequential decisions in health.
Health institutions designed with the same rigor as a region's most ambitious infrastructure.
Independence. Rigor. Candour. Discretion. A long horizon.
Cordelia is led by its founding principal, and draws on a network of physicians, economists, and strategists across the Gulf and London — brought to the work they touch, engagement by engagement, rather than carried on a masthead.
Professor of public health and epidemiology, and consultant public health physician. The practice was established in 2016 as Yamam Health Consultancy, and carries that record forward under the Cordelia name.
Associates are named on the work they contribute to, by invitation and by fit. The bench grows as the standing does.
Each engagement is bespoke, but the work tends to fall into seven disciplines — drawn on singly or together as the question demands.
Designing the architecture, financing, and governance of health systems that hold under pressure — from national strategy to the mechanics of delivery.
Surveillance design, outbreak analytics, and population-health strategy built for decisions, not dashboards — health security that anticipates rather than reacts.
Responsible AI, data governance, and digital architecture for institutions that must be able to trust their own systems — and answer for them.
Market access, regulatory pathways, and portfolio strategy for the science that becomes medicine — from platform thesis to commercial reality.
Research strategy, funding architecture, and partnership design — building programs of work that withstand scrutiny and earn standing.
Feasibility, due diligence, and investment theses for capital entering health and life sciences — independent reads, free of the deal's own momentum.
Building the judgment of the people who will lead health institutions next — because the most durable advice is the kind an institution no longer needs.
The discipline is constant; the question is never the same. We work across the institutions that shape how health is governed, financed, and delivered.
Designing national health strategy, financing, and security under real constraints — and the institutional capacity to sustain them past a single administration.
Turning research ambition into institutional capability and credible standing — research strategy, funding architecture, and the design of work that lasts.
Aligning clinical excellence with the systems and economics that sustain it — operating models, governance, and the long arc of institutional design.
Charting the path from promising science to market and regulatory reality — access strategy, evidence design, and a clear-eyed read of the field ahead.
Independent diligence and market intelligence for capital entering health and life sciences — a second mind, free of the deal's own gravity.
Designing and evaluating programs that have to work in the world, not only on paper — measurable architecture for measurable impact.
We license no software and represent no vendor. That absence is the point: it is what lets the advice be only about your interest, and lets us say the inconvenient thing when it needs saying.
Our work is grounded in method — epidemiology, evidence, and the habits of peer review — so that a recommendation survives not only the boardroom but the journal, the regulator, and the years that follow.
Depth is the easy part; clarity is the discipline. We translate complexity into decisions a leader can defend — without losing what the complexity was trying to protect.
Based in Muscat and built for the GCC, with a frame of reference drawn from global health practice — so the advice is at once locally grounded and internationally credible.
Cordelia publishes policy briefs, commentary, and white papers on the problems beneath the headlines. Four lines of inquiry shape that work.
The investment logic of Oman’s health transition — and why a market being created by policy is being mispriced by instinct.
Read the briefing →Surveillance is called the eyes of a health system. But sight is selective — and what a system declines to count, it slowly learns not to see.
Read the essay →How systems are financed, governed, and built to hold under shock — and what separates the ones that recover from the ones that fracture.
Seeing outbreaks early and reading them well — the design of surveillance that informs decisions rather than merely recording events.
What it takes for an institution to use artificial intelligence responsibly — and to remain accountable for the systems it comes to rely on.
How scientific promise becomes available medicine — the strategy, the capital, and the distance between a platform and a patient.
This is the first of the firm's published essays. Further briefs and commentary will follow as the work moves into the open.
Request early briefs →The Review also publishes invited work — essays and insights from researchers, clinicians, and colleagues whose argument meets the standard the firm is built on. Contributions are commissioned by invitation, edited before they appear, and chosen on the merit of the thinking rather than the closeness of the acquaintance.
Propose a piece →If you are weighing a decision that warrants independent counsel, we would be glad to hear from you. A few lines about the institution and the question in front of you is enough to begin.
This opens your email client with the message drafted. You can also write to us directly at the address opposite.